As Roche Explores Using 454 Platform for HLA Typing, Some US Labs Remain Cautious

454 says some of its customers outside the US are close to using the GS FLX for clinical HLA typing. It is also working with the FDA to find ways to provide the tool to US testing labs, some of which doubt it is robust and cheap enough for such use.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.